Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001117480-17-000017
Filing Date
2017-05-09
Accepted
2017-05-09 07:58:53
Documents
46
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a20170331cmrx10-qdocument.htm 10-Q 936061
2 EXHIBIT 10.2 a20170331cmrxex-102.htm EX-10.2 42726
3 EXHIBIT 10.3 a20170331cmrxex-103.htm EX-10.3 18601
4 EXHIBIT 31.1 a20170331cmrxex-311.htm EX-31.1 9660
5 EXHIBIT 31.2 a20170331cmrxex-312.htm EX-31.2 9679
6 EXHIBIT 32.1 a20170331cmrxex-321.htm EX-32.1 7190
7 EXHIBIT 32.2 a20170331cmrxex-322.htm EX-32.2 7292
  Complete submission text file 0001117480-17-000017.txt   3874594

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cmrx-20170331.xml EX-101.INS 783043
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20170331.xsd EX-101.SCH 23566
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmrx-20170331_cal.xml EX-101.CAL 49465
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmrx-20170331_def.xml EX-101.DEF 116265
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20170331_lab.xml EX-101.LAB 324393
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20170331_pre.xml EX-101.PRE 191984
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35867 | Film No.: 17824686
SIC: 2834 Pharmaceutical Preparations